Eur Rev Med Pharmacol Sci 2022; 26 (8): 2647-2647
DOI: 10.26355/eurrev_202204_28592

Author Correction: Correlation between expression levels of lncRNA UCA1 and miR-18a with prognosis of hepatocellular cancer

Z. Zhang, J.-Z. Li, Z.-W. Wei, F. Li, H.-M. Li, Y. Xiao, Y.-Q. Qin

Departments of Hepatobiliary Surgery, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, China


Correction to: European Review for Medical and Pharmacological Sciences 2020; 24 (7): 3586-3591–DOI: 10.26355/eurrev_202004_20820–PMID: 32329833, published online on 15 April 2020.

After publication, the authors noticed some mistakes in the manuscript and applied to issue the following changes: the legend of Table I, the date of enrollment of the patients in the section titled “Baseline Characteristics of HCC Patients”, the date of follow-up reported in the abstract and in the section entitled “Postoperative Follow-Up”.

The authors also applied to modify the survival curve of Figure 3 due to misuse of data in the statistical analysis.

There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause.

Correlation between expression levels of lncRNA UCA1 and miR-18a with prognosis of hepatocellular cancer

Free PDF Download

To cite this article

Z. Zhang, J.-Z. Li, Z.-W. Wei, F. Li, H.-M. Li, Y. Xiao, Y.-Q. Qin
Author Correction: Correlation between expression levels of lncRNA UCA1 and miR-18a with prognosis of hepatocellular cancer

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 8
Pages: 2647-2647
DOI: 10.26355/eurrev_202204_28592